Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3976772 | Brachytherapy | 2012 | 6 Pages |
Abstract
Heterogeneity corrections on high-dose rate plans were found to have only a small dosimetric impact over TG-43-based dose calculations for both conventional Point-A and volume-optimized plans.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel E. Hyer, Arshin Sheybani, Geraldine M. Jacobson, Yusung Kim,